Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations, said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc, in a May 2, 2025, statement
The drug, the concentration in mg/mL, the total volume in the vial, your prescribed dose and how it is to be measured
It is the world's first sustained-release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes that activates both the GLP-1 and GIP receptors
This warrants the need for pharmacologic interventions in a number of patients
US$ 29.25
US$ 22.23
US$ 20.83
US$ 20.03
US$ 28.59
US$ 29.01
US$ 22.37
US$ 24.85
US$ 25.39
US$ 22.57
US$ 22.85
US$ 28.33
